Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.
Cancer Discov
; 9(7): 944-961, 2019 07.
Article
in En
| MEDLINE
| ID: mdl-31040105
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Cyclophosphamide
/
Alkylating Agents
/
Alemtuzumab
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Discov
Year:
2019
Type:
Article